JAMA Network podcast

JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

10/24/2024
0:00
20:41
Rewind 15 seconds
Fast Forward 15 seconds

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

More episodes from "JAMA Network"